6 completed, 2 recruiting, 1 active not recruiting, 1 terminated. 10 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 6, Recruiting 2, Active not recruiting 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Verbal Behavior: new trials by email Literature Review of Verbal Behavior trials Research Report on Verbal Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia Neflamapimod, Placebo - Nonfluent Variant Primary Progressive Aphasia (nfvPPA) | Phase 2 | Active not recruiting | EIP Pharma Inc | 20 | 2025-10-02 | 2026-07-06 |
| Generalization With AI Navigation Using StaRt AI-guided maintenance training with visual-acoustic biofeedback, Treatment as Usual (TAU) - Speech Sound Disorder | Phase 2 | Recruiting | New York University | 76 | 2024-12-18 | 2026-05-13 |
| Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial Visual-acoustic biofeedback - Speech Sound Disorder | Phase 2 | Recruiting | New York University | 76 | 2024-07-01 | 2026-11-03 |
| Methylphenidate in Childhood Apraxia of Speech Methylphenidate Hydrochloride, Placebo - Childhood Apraxia of Speech | Phase 2 | Completed | Murdoch Childrens Research Institute | 18 | 2022-03-14 | 2026-10-13 |
| Visual Acoustic Biofeedback for RSE Via Telepractice Visual-Acoustic Biofeedback Treatment, No Treatment - Speech Sound Disorder | Phase 2 | Completed | Montclair State University | 40 | 2022-01-15 | 2026-02-17 |
| Building Sentences With Preschoolers Who Use AAC AAC Generative Language Intervention, Standard of Care / Business as Usual - Down Syndrome, Speech and Language Disorder | Phase 2 | Completed | University of Central Florida | 70 | 2018-05-11 | 2024-01-08 |
| SPI-1005 for the Treatment of Patients With Meniere's Disease 200mg SPI-1005 BID, 400mg SPI-1005 BID, Placebo - Meniere's Disease | Phase 2 | Completed | Sound Pharmaceuticals, Incorporated | 149 | 2017-09-28 | 2023-09-18 |
| Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma Transoral Robotic Surgery (TORS), Modified Barium Swallow (MBS), Questionnaires - Oropharyngeal Cancer | Phase 2 | Terminated | M.D. Anderson Cancer Center | 1 | 2014-09-23 | 2017-12-15 |
| Expiratory Muscle Training in Patients With Parkinson's Disease EMST - Active Treatment, sham EMST - Parkinson's Disease | Phase 1 / Phase 2 | Completed | University of Florida | 90 | 2004-01-01 | 2011-09-20 |
| Cleft Palate Surgery and Speech Development Furlow double z-plasty palatoplasty palate repair, Von Langenbeck palatoplasty palate repair - Cleft Lip, Cleft Palate | Phase 2 | Completed | University of Florida | 475 | 1996-02-01 | 2011-09-20 |
Speech (9) · Speech Sound Disorder (4) · Language Disorders (2) · Speech Intelligibility (2) · Aphasia (1) · Aphasia, Primary Progressive (1) · Apraxias (1) · Attention Deficit Disorder with Hyperactivity (1) · Brain Diseases (1) · Carcinoma, Squamous Cell (1) · Central Nervous System Diseases (1) · Cleft Lip (1) · Cleft Palate (1) · Cough (1) · Down Syndrome (1)
Behavior (10) · Communication (10) · Communication Disorders (5) · Mental Disorders (5) · Neurodevelopmental Disorders (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Nervous System Diseases (4) · Neurologic Manifestations (4) · Neurobehavioral Manifestations (3) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Otorhinolaryngologic Diseases (2) · Stomatognathic Diseases (2)
Commerce (1) · Methylphenidate (1) · Standard of Care (1) · Surveys and Questionnaires (1) · Therapeutics (1) · ebselen (1)
New York University (2) · University of Florida (2) · EIP Pharma Inc (1) · M.D. Anderson Cancer Center (1) · Montclair State University (1) · Murdoch Childrens Research Institute (1) · Sound Pharmaceuticals, Incorporated (1) · University of Central Florida (1)
United States (9) · Australia (1) · Brazil (1) · United Kingdom (1)
Angela Morgan, PhD (1) · Christine M Sapienza, Ph.D. (1) · Elaine R. Hitchcock, PhD (1) · Jonathan Kil, MD (1) · Michael E. Kupferman, MD (1) · William N Williams, Ph.D (1)
PMID 19029430, PMID 34510123, PMID 39871189
R01DC017476 (2), R01DC016321 (1), R01DE010437 (1), R15DC019775 (1)